Ann Baker and John Cole are speaking on this topic. This webinar will examine the motivations for collaboration between biopharma and academia – two different worlds. Crucially, we will also reflect on why the outcomes of such collaborations often disappoint and consider some of the interventions that both parties can make to ensure a successful outcome. We will look at how to bridge the gap between academia and biopharma.
For more information on this event, click here.
The impact of price-based vaccine procurement programmes
The focus on the role of vaccines in addressing global health challenges has intensified in recent months in light of the spread of coronavirus. Specifically,...